Disease Synopsis
Overview
Drugs and Clinical Candidates
Clinical Trials (visual)
Clinical Trials (text)
Cell Line Models
Chemistry

Head and Neck Cancer - Overview - Disease Synopsis

Drugs & Clinical Candidates


8 drugs have received FDA approval for Head and Neck Cancer . Amifostine, Bleomycin Sulfate, Cetuximab, Docetaxel, Hydroxyurea, Methotrexate Sodium, Nivolumab and Pembrolizumab
282 drugs have a clinical trial registered for Head and Neck Cancer.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Clinical Trials


There are 1681 clinical trials for Head and Neck Cancer,
919 of which have one or more drug interventions,
762 with no drug intervention.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Cell Line Models


There are 0 Cell Line Models for Head and Neck Cancer.

Source: COSMIC
(see details)

Chemistry


There are 1159 Compounds which have been tested in Head and Neck Cancer , 767 <= 500nM potency.

Source: ChEMBL
(see details)

Mappings


Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Head and Neck Cancer:
Facial Neoplasms
Head and Neck Neoplasms
Squamous Cell Carcinoma of Head and Neck

The following terms have been mapped from cancer.gov to Head and Neck Cancer:
Head and neck cancer (certain types)
Squamous cell carcinoma of the head and neck (SCCHN)
Squamous cell carcinoma of the head and neck (excluding the lip) that is locally advanced. It is used with chemoradiation
Squamous cell carcinoma of the head and neck that has metastasized or recurred (come back) in patients whose disease got worse during or after treatment with platinum chemotherapy
Squamous cell carcinoma of the head and neck that has metastasized or recurred (come back) in patients whose disease got worse during or after treatment with platinum chemotherapy.????
Squamous cell carcinoma of the head and neck that is locally advanced and cannot be treated with surgery
Squamous cell carcinoma of the head and neck that is:Local or advanced. It is used with radiation therapy
Xerostomia (dry mouth). It is used to decrease dryness in the mouth caused by radiation therapy after surgery in some patients with head and neck cancer